Insider Trading & Ownership - Pontifax Management 4 G.P. (2015) Ltd.

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Pontifax Management 4 G.P. (2015) Ltd.
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-05-13
Purchase
2021-05-17
07:03 am
Eloxx Pharmaceuticals Inc.ELOXPontifax Management 4 G.P. (2015) Ltd.
Pontifax (China) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (Israel) IV L.P.
Pontifax IV GP L.P.
10% Owner
5,925,925$1.35$7,999,999616,592
(Indirect)
View
2020-11-17
Purchase
2020-11-19
4:38 pm
Keros Therapeutics Inc.KROSPontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
60,000$50$3,000,000155,262
(Indirect)
View
2020-04-13
Purchase
2020-04-13
5:18 pm
Keros Therapeutics Inc.KROSPontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
437,499$16$6,999,984149,262
(Indirect)
View
2019-11-11
Purchase
2019-11-13
7:10 pm
89bio Inc.ETNBKariv Tomer
Pontifax (Israel) V L.P.
Pontifax (Cayman) V L.P.
Pontifax (China) V L.P.
Pontifax 5 G.P. L.P.
Pontifax Management 4 G.P. (2015) Ltd.
Pontifax Late Stage GP Ltd.
Pontifax Late Stage Fund L.P.
Director
10% Owner
250,000$16$4,000,0001,134,671
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-11-29
Exercise
2022-11-30
4:42 pm
N/A
N/A
Keros Therapeutics Inc.KROSPontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
7,176$0.00011,226,412
(Indirect)
View
2022-11-29
Exercise
2022-11-30
4:42 pm
N/A
2023-10-07
Keros Therapeutics Inc.KROSPontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
7,176$01,226,412
(Indirect)
View

Ownership(A)
2022-11-30
4:37 pm
N/A
2023-10-07
Keros Therapeutics Inc.KROSPontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
0$07,176
(Indirect)
View
2020-05-20
Option Award
2020-05-22
4:10 pm
N/A
2030-05-20
Eloxx Pharmaceuticals Inc.ELOXPontifax Management 4 G.P. (2015) Ltd.
Pontifax IV GP L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax (Israel) IV L.P.
Pontifax Management III G.P. (2011) Ltd.
Pontifax Management Fund III L.P.
Pontifax (Cayman) III L.P.
Pontifax (Israel) III L.P.
10% Owner
40,000$040,000
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc.KROSPontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
3,545,100$0149,262
(Indirect)
View

Ownership
2020-04-07
8:14 pm
N/A
N/A
Keros Therapeutics Inc.KROSPontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
0$04,297,008
(Indirect)
View
2019-11-13
Conversion
2019-11-13
7:10 pm
N/A
N/A
89bio Inc.ETNBKariv Tomer
Pontifax (Israel) V L.P.
Pontifax (Cayman) V L.P.
Pontifax (China) V L.P.
Pontifax 5 G.P. L.P.
Pontifax Management 4 G.P. (2015) Ltd.
Pontifax Late Stage GP Ltd.
Pontifax Late Stage Fund L.P.
Director
10% Owner
6,384,672$01,134,671
(Indirect)
View

Ownership
2019-11-08
7:17 pm
N/A
N/A
89bio Inc.ETNBKariv Tomer
Pontifax (Israel) V L.P.
Pontifax (Cayman) V L.P.
Pontifax (China) V L.P.
Pontifax 5 G.P. L.P.
Pontifax Management 4 G.P. (2015) Ltd.
Director
10% Owner
0$0884,671
(Indirect)
View
(A) Indicate amendment filing.